

Is Crexont in shortage in 2026? Get the latest update on Crexont availability, what's causing supply issues, and what patients can do right now.
If you've been struggling to find Crexont (Carbidopa/Levodopa extended-release capsules) at your pharmacy, you're not imagining things. Many Parkinson's disease patients across the United States are reporting difficulty filling their Crexont prescriptions in early 2026.
Here's everything you need to know about the current Crexont supply situation, what's behind it, and what you can do.
As of February 2026, Crexont is not listed on the FDA's official Drug Shortages Database. This means the FDA has not formally classified it as being in shortage. However, that doesn't mean it's easy to find.
The reality is that Crexont has limited distribution. Because it is a brand-new medication (FDA-approved August 2024, launched late 2024) with no generic version, not all pharmacies stock it. Some pharmacies and coupon sites like GoodRx have noted that Crexont "isn't available in pharmacies at this time" in certain areas.
Several factors are contributing to the difficulty patients face when trying to fill their Crexont prescription:
For patients who depend on Crexont to manage their Parkinson's symptoms, limited availability can mean:
If you are experiencing motor fluctuations or worsening symptoms because you can't get Crexont, contact your neurologist right away. They can help you find a temporary alternative.
Amneal Pharmaceuticals has taken several steps to improve access to Crexont:
Here are actionable steps to help you get your Crexont prescription filled:
While there's no exact date, availability is expected to improve steadily throughout 2026 as:
We'll continue to update this page as new information becomes available. Bookmark this page and check back regularly.
For more information about Crexont, read our other guides:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.